161 related articles for article (PubMed ID: 10341713)
1. Apoptosis and therapy.
Schmitt CA; Lowe SW
J Pathol; 1999 Jan; 187(1):127-37. PubMed ID: 10341713
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
3. Apoptomirs: small molecules have gained the license to kill.
Vecchione A; Croce CM
Endocr Relat Cancer; 2010 Mar; 17(1):F37-50. PubMed ID: 19815577
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
5. Killing tumours by ceramide-induced apoptosis: a critique of available drugs.
Radin NS
Biochem J; 2003 Apr; 371(Pt 2):243-56. PubMed ID: 12558497
[TBL] [Abstract][Full Text] [Related]
6. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
7. TRAIL as a target in anti-cancer therapy.
Wu GS
Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
[TBL] [Abstract][Full Text] [Related]
8. [Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development].
Akaza H; Aiba K; Isonishi S; Ogawa O; Shibuya M; Sone S; Tsuruo T; Noguchi S; Hinotsu S; Kono S; Mikami O; Blackledge G; Vose B; Stribling D
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1681-93. PubMed ID: 11057319
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
de Bruin EC; Medema JP
Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic versus genotoxic potential of anti-tumor agents: a concept of duality in unity.
Bajic V; Milicevic Z; Potpervic-Spremo B; Nedeljkovic-Kurepa A
Med Hypotheses; 2003; 61(5-6):643-50. PubMed ID: 14592801
[TBL] [Abstract][Full Text] [Related]
11. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Katsman A; Umezawa K; Bonavida B
Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602
[TBL] [Abstract][Full Text] [Related]
12. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge].
Belka C; Betsch A; Marini P; Jendrossek V; Bamberg M; Budach W
Strahlenther Onkol; 2003 Mar; 179(3):141-51. PubMed ID: 12627256
[TBL] [Abstract][Full Text] [Related]
13. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
14. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.
Kim R; Emi M; Tanabe K; Uchida Y; Arihiro K
Eur J Surg Oncol; 2006 Apr; 32(3):269-77. PubMed ID: 16431074
[TBL] [Abstract][Full Text] [Related]
15. The role of annexins in tumour development and progression.
Mussunoor S; Murray GI
J Pathol; 2008 Oct; 216(2):131-40. PubMed ID: 18698663
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, Bcl-2 antisense, and cancer therapy.
Piro LD
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):5-10. PubMed ID: 15651171
[TBL] [Abstract][Full Text] [Related]
17. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Ashkenazi A
Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
[TBL] [Abstract][Full Text] [Related]
18. Is TRAIL the holy grail of cancer therapy?
Newsom-Davis T; Prieske S; Walczak H
Apoptosis; 2009 Apr; 14(4):607-23. PubMed ID: 19194800
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in the development and treatment of cancer.
Gerl R; Vaux DL
Carcinogenesis; 2005 Feb; 26(2):263-70. PubMed ID: 15375012
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death and cancer.
Sun Y; Peng ZL
Postgrad Med J; 2009 Mar; 85(1001):134-40. PubMed ID: 19351640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
